Page 4 - Casdin Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Avidity Biosciences Announces Oversubscribed $400 Million Private Placement

Funding from new and existing investors, including Adage Capital Partners LP, Boxer Capital, Casdin Capital, LLC, Farallon, Janus Henderson Investors, RA Capital Management, RTW Investments, Wellington Management, as well as multiple large investment.

San diegoUnited statesNew zealand generalNew zealandNavjot raiGeoffrey grandeCasdin capitalAvidity biosciences incExchange commissionBiosciences announces oversubscribedAdage capital partnersBoxer capitalJanus henderson investorsWellington managementAvidity biosciencesAntibody oligonucleotide conjugates

Ginkgo Bioworks Acquires Patch Biosciences, Expanding Suite of Genetic Medicine Capabilities Available to Customers

Ginkgo Bioworks Acquires Patch Biosciences, Expanding Suite of Genetic Medicine Capabilities Available to Customers
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJason kellyAndreessen horowitzExchange commissionCell therapy servicesTherapeutics servicesGene therapy servicesGinkgo bioworksCasdin capitalTherapy servicesIntegrating patchSensible biotechnologiesPatch biosciencesLooking statements

Ginkgo Bioworks Acquires Patch Biosciences, Expanding Suite Of Genetic Medicine Capabilities Available To Customers

Ginkgo Bioworks Acquires Patch Biosciences, Expanding Suite Of Genetic Medicine Capabilities Available To Customers
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesInstagram ginkgobioworksAndreessen horowitzJason kellyCell therapy servicesExchange commissionGinkgo gene therapy servicesTherapeutics servicesGene therapy servicesGinkgo bioworksPatch biosciencesCasdin capitalBioworks acquires patch biosciencesExpanding suiteGenetic medicine capabilities availableIntegrating patch

Institutional investors own a significant stake of 44% in GeneDx Holdings Corp (NASDAQ:WGS)

Key Insights Institutions' substantial holdings in GeneDx Holdings implies that they have significant influence over.

Mount sinai schoolGenedx holdingsGenedx holdingCasdin capitalHealth incGenedx holdings corpPublic company ownershipInstitutional ownership tell us about genedx holdingsMount sinai school of medicineEndowment armGenedx holdings corpGenedx holdingsNsider ownership

Sana Biotechnology (NASDAQ:SANA) Raised to Buy at HC Wainwright

HC Wainwright upgraded shares of Sana Biotechnology (NASDAQ:SANA – Free Report) from a neutral rating to a buy rating in a report published on Tuesday morning, Marketbeat.com reports. They currently have $12.00 price objective on the stock. HC Wainwright also issued estimates for Sana Biotechnology’s FY2027 earnings at ($0.80) EPS and FY2028 earnings at ($0.64) […]

York mellon corpTd asset management incSana biotechnology incCasdin capitalSana biotechnology company profileSana biotechnologyFree reportModerate buyGet free reportWorld investorsMichigan retirement systemNew york mellon corpManagement incSana biotechnology dailyNasdaq sanaHc wainwright